ATLASATLAS fair value
€18.88
Above fair value · 35% premium
Range: €15–€24Fair valuePrice
SCHOTT Pharma AG & Co. (1SXP.XETRA)
SCHOTT Pharma AG & Co. stock price today, ATLAS forecast and fair value
Healthcare · Medical Instruments & Supplies · Xetra (Deutsche Börse) · Germany
€25.50▲ 0.00%
Prices as of Oct 27, 2026 · EUR
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on SCHOTT Pharma AG & Co. in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On SCHOTT Pharma AG & Co.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates SCHOTT Pharma AG & Co.'s fair value at about €18.88 per share (reasonable range: €14.62 to €24.40). At €25.50, the stock trades 35% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives SCHOTT Pharma AG & Co. a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between €24.28 and €26.90; in 9 out of 10, between €22.17 and €29.46. Estimated annual volatility is 27%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- €3.7B
- Market cap (USD)
- $4.1B
- P/E ratio
- 28.9
- Dividend yield
- 0.71%
- 52-week high
- €26.20
- 52-week low
- €12.62
- Revenue (12 months)
- €1.0B
- Gross margin
- 31.2%
- Operating margin
- 17.4%
- Net margin
- 13.4%
- Beta
- 0.87
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. SCHOTT Pharma AG & Co. sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 1SXP.XETRA has traded between €12.62 and €26.20. Today it is 2.7% below that high and 102% above its low.
On the business: net margin is 13.4%; it trades at 28.9 times earnings.
Its beta is 0.87: it moves roughly in line with the market.
About the company
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.
Want to see everything about SCHOTT Pharma AG & Co.?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is SCHOTT Pharma AG & Co. (1SXP.XETRA) fair value?
About €18.88 per share according to ATLAS (reasonable range: €14.62 to €24.40). With the stock at €25.50, it is 35% above it.
What is the chance 1SXP.XETRA goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, 1SXP.XETRA ends the month between €24.28 and €26.90.
How big is SCHOTT Pharma AG & Co. and what is its P/E ratio?
SCHOTT Pharma AG & Co.'s market capitalization is €3.7B. Its price-to-earnings (P/E) ratio is 28.9: you pay €28.9 for each €1.00 of yearly earnings.
Does SCHOTT Pharma AG & Co. pay a dividend?
Yes. 1SXP.XETRA's current dividend yield is 0.71% at today's price (€25.50).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer